Market Overview
Oncology applications are leading growth in the South America personalized medicine market, driven by the introduction of targeted therapies and companion diagnostics. Personalized oncology tailors treatment to tumor molecular profiles, improving response rates and reducing toxicity. The market is projected to grow through 2030, fueled by precision oncology adoption.

The South America Personalized Medicine Market benefits from expanding access to genomic testing and targeted therapies. Brazil and Argentina are leading markets, with growing adoption in Colombia and Chile.

Current Market Landscape
Hospital molecular pathology laboratories provide tumor profiling. Key players include Roche, Novartis, and Pfizer. Access to targeted therapies varies by country and insurance coverage.

Emerging Trends
Liquid biopsy is enabling non-invasive monitoring. Comprehensive genomic profiling is identifying actionable mutations. Clinical trials are expanding access to novel therapies.

Future Outlook
Oncology is expected to remain the dominant application, driving market growth through 2030.

Conclusion
Oncology applications are leading growth in South America's personalized medicine market, improving cancer outcomes.

FAQ
Q1: How is personalized medicine used in oncology?
A: Tumor profiling guides selection of targeted therapies.
Q2: What is comprehensive genomic profiling?
A: Testing multiple genes to identify actionable mutations.

#PrecisionOncology #PersonalizedMedicine #SouthAmerica